MYL9 and colorectal carcinoma: In the PrognoScan database, we also found a strong association between MYL9 overexpression and CRC OS and DFS (GSE17536, OS hazard ratio [HR] = 1.26, 95% confidence interval [CI] 1.00–1.60, p = 0.0208; DFS HR = 1.37, 95% CI 1.05–1.78, p = 0.032; GSE14333, DFS HR = 1.37, 95% CI 1.09–1.70, p = 0.00573).